TIBSOVO cpr pell 250 mg bte 60 pce

7680690770013 CH-69077 L01XM02 07.16.1.
TIBSOVO cpr pell 250 mg bte 60 pce
TIBSOVO cpr pell 250 mg bte 60 pce
TIBSOVO cpr pell 250 mg bte 60 pce
1 / 3
google

Details

Product number
6907701
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
ivosidenibum 250 mg, hypromellosi acetas succinas, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, hypromellosum, E 171, lactosum monohydricum 10 mg, triacetinum, E 132, pro compresso obducto corresp. natrium max. 5.2 mg.

Articles (1)

Tibsovo 250 mg, comprimés pelliculés
Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
24/05/2025
Professional SmPC
Français
24/05/2025
Professional SmPC
Italien
24/05/2025
Patient information leaflet
Allemand
11/07/2024
Patient information leaflet
Français
11/07/2024
Patient information leaflet
Italien
11/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI

Authorization holder

Servier (Suisse) SA

1202 Genève

Authorization information

Swissmedic authorization number
69077
Drug name
Tibsovo, comprimés pelliculés
Galenic form
FILM
ATC Code
L01XM02
Authorization status
Z
Dispensation category
A
First authorization
13/06/2024
Authorization expiration date
12/06/2029
IT number
07.16.1.
Domain
Human medicine

Packaging details

Description (FR)
TIBSOVO cpr pell 250 mg bte 60 pce
Description (DE)
TIBSOVO Filmtabl 250 mg Ds 60 Stk
Market launch
13/06/2024
Narcotic (BTM)
No